[Role of dihydralazine in the treatment of chronic cardiac insufficiency].

Abstract

Dihydralazine, sold under the name of Nepressol, is the derivative of the hydrazinophthalazines used in France for the treatment of severe cardiac failure. The hydrazinophthalazines act in cardiac failure by decreasing systemic arterial resistance and increasing cardiac output without causing tachycardia or increasing myocardial contractility in normal or… (More)

Topics

Cite this paper

@article{Morand1985RoleOD, title={[Role of dihydralazine in the treatment of chronic cardiac insufficiency].}, author={Philippe C. Morand and Marcel Baudouy and Julien Camous and Pierre Gibelin and Laurent Leborgne}, journal={Annales de medecine interne}, year={1985}, volume={136 3}, pages={266-71} }